This was the stock's second consecutive day of losses.

Tilray THC50 CBD50 (25ml): A high-potency 1:1 medical cannabis extract designed for patients requiring higher cannabinoid content, offering an option for those who need stronger therapeutic effects ...

Shares of Tilray Brands Inc. TLRY advanced 1.05% to $0.95 Wednesday, on what proved to be an all-around mixed trading session ...

The Company's extensive cultivation capacity is designed to provide a consistent and reliable supply of premium cannabis products to over 20 legal cannabis markets worldwide. Tilray's commitment ...

Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today ...

Target has expanded its beauty assortment with more than 2,000 products and nearly 50 new brands, with 90% of the new ...

Tilray Medical, a division of Tilray Brands (TSX,NASDAQ:TLRY), is adding new cannabis extract products to its German medical ...

Tilray's major story during the year was its concentrated attempts to diversify away from marijuana, which is hardly a ringing endorsement of its efforts with the core products. Bursting with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Tilray Brands, Inc. (TLRY) ended the recent trading session at $0.95, demonstrating a +1.05% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily ...